Lissamine Green 1% Eye Drops
Brand names: Lissamine Green Ophthalmic Solution
Lissamine green is an ophthalmic diagnostic dye applied to the eye to assess the health of the ocular surface, particularly in dry eye disease.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It stains devitalised and degenerate epithelial cells and areas of the cornea and conjunctiva lacking an adequate protective mucin coating, highlighting ocular surface damage for examination.
Prescribing in practice
- It is a diagnostic agent for clinician-applied ocular surface examination, not a treatment, and should be instilled and interpreted by a trained eye care professional.
- It is generally well tolerated and causes less stinging than rose bengal, making it useful for ocular surface staining.
- Examine the stained ocular surface promptly after application as staining is assessed during slit-lamp evaluation.
Monitoring
No ongoing monitoring is required as it is used once at the point of clinical assessment of the ocular surface.
Counselling the patient
- Explain that a harmless coloured dye is being placed in the eye to check the surface during examination.
- Mild transient irritation may occur but settles quickly after the examination.
Evidence & guidelines
Lissamine green staining is a standard component of ocular surface assessment in dry eye disease evaluation in ophthalmic practice.
Reference: TFOS DEWS II Diagnostic Methodology Report (Ocul Surf 2017); van Bijsterveld OP, Arch Ophthalmol 1969; SPC Lissamine Green Ophthalmic; NICE TA369; Confirm identity and dosing against the manufacturer SPC (eMC) and NICE. Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- National Early Warning Score 2 (NEWS2) · Early Warning
- Duke Criteria for Infective Endocarditis · Diagnosis
- Sgarbossa Criteria for MI in LBBB · Diagnosis
- Framingham Heart Failure Diagnostic Criteria · Heart Failure
- Marburg Heart Score · Chest Pain
- 2023 Duke-ISCVID Criteria for Infective Endocarditis · Infective Endocarditis
- Acute Red Eye / Vision Loss Screen · RCOphth 2020; NICE CKS
- Idiopathic Intracranial Hypertension · ABN; consensus 2018
- Acute Red Eye Assessment · RCOphth / AAO
- Acute Angle Closure Glaucoma · RCOphth / EGS Guidelines
- Retinal Detachment · RCOphth Guidelines / EURETINA
- Diabetic Retinopathy — Screening and Management · NICE NG28 2016 / NHS DES Programme